General
Building on links across diverse neurodegenerative disorders, such as Alzheimer’s, Parkinson’s, amyotrophic lateral sclerosis (ALS) and the spastic paraplegias, this conference will provide genetic and functional insights into the underlying etiology of neuronal cell death.
Discussions will centre on neurodegeneration-related human genetics, trafficking dysregulation and challenges of translating mechanistic advances into therapeutics. The programme will highlight cutting-edge techniques, including the use of large-scale data sets and various ’omics’ approaches.
The conference will bring together clinicians specialising in neurology, along with researchers from academia and industry involved in neurodegeneration across the spectrum of human genetics, fundamental cell biology and drug development.
The programme will consist of invited talks, oral presentations selected from abstracts, posters, poster pitches, and networking opportunities for a highly interactive meeting. This conference will be a hybrid meeting – with onsite or virtual attendance.